Oncology & Cancer

Dual-agent PET/MR with time of flight detects more cancer

Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F-sodium fluoride (18F-NaF) followed by quantitative scanning significantly improves image quality and detection of bone metastases ...

Oncology & Cancer

Glowing tumors light a path to cancer treatment

Every year, 200,000 women worldwide are diagnosed with ovarian cancer, often in its late stages. Ovarian cancer is very hard to detect in its early stages, and once it is detected, the body is already riddled with dozens ...

Cardiology

MRI risk model may cut biopsy use in suspected prostate cancer

(HealthDay)—A risk model including magnetic resonance imaging (MRI)-derived parameters may reduce the number of unnecessary biopsies among patients with suspected prostate cancer, according to a study published online Feb. ...

Oncology & Cancer

Theranostic PET takes on both ovarian and prostate cancer

A first-in-human study revealed at the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) shows how a powerful new drug finds and attaches itself to the ovarian and prostate cancer cells ...

Oncology & Cancer

Breast MRI may lead to overdiagnosis for older women

Magnetic resonance imaging (MRI) of the breast has become part of routine medical care for many women undergoing breast cancer surgery, but these highly sensitive tests might identify health problems that would not otherwise ...

Oncology & Cancer

Iodine-125 interstitial implant feasible for prostate cancer

(HealthDay)—Iodine-125 permanent interstitial implantation is associated with long-term, biochemical control of localized prostate cancer, according to a study published online March 28 in the Journal of Medical Imaging ...

page 34 from 40